| Delaware                                                       |   | 35-1996126                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |
|                                                           |   |                                 |
| 3724 North State Road 15, Warsaw, Indiana                      |   | 46582                                |
| (Address of principal executive offices)                       |   | (Zip Code)                           |
|                                                           |   |                                 |
| (574) 268-2252                                                 |   |                                 |
| (Registrant’s telephone number, including area code)     |   |                                 |

|   | Large accelerated filer  ̈                                             |   | Accelerated filerþ          |
|--------|---------------------------------------------------------------------------------|--------|----------------------------------|
|   | Non-accelerated filer  ̈ (Do not check if a smaller reporting company) |   | Smaller reporting company  ̈ |

----

| PART I FINANCIAL INFORMATION |                                                                                                     |   |
|-----------------------------------|----------------------------------------------------------------------------------------------------------|--------|
|                              |                                                                                                     |   |   |
| Item 1                       | Financial Statements:                                                                                    |   | 2 |
|                              |                                                                                                     |   |   |
|                              | Condensed Consolidated Balance Sheets: As of April 2, 2011 and January 1, 2011                      |   | 3 |
|                              |                                                                                                     |   |   |
|                              | Condensed Consolidated Statements of Operations: Three Months Ended April 2, 2011 and April 3, 2010 |   | 4 |
|                              |                                                                                                     |   |   |
|                              | Condensed Consolidated Statements of Cash Flows: Three Months Ended April 2, 2011 and April 3, 2010      |   | 5 |
|                              |                                                                                                     |   |   |
|                              | Notes to Condensed Consolidated Financial Statements                                                     |   | 6 |
|                              |                                                                                                     |   |   |
| Item 2                       | Management’s Discussion and Analysis of Financial Condition and Results of Operations              |   | 10 |
|                              |                                                                                                     |   |   |
| Item 3                       | Quantitative and Qualitative Disclosures about Market Risk                                               |   | 14 |
|                              |                                                                                                     |   |   |
| Item 4                       | Controls and Procedures                                                                                  |   | 14 |
|                              |                                                                                                     |   |   |
| PART II OTHER INFORMATION    |                                                                                                     |   |
|                              |                                                                                                     |   |   |
| Item 1                            | Legal Proceedings                                                                                        |   | 14 |
|                              |                                                                                                     |   |   |
| Item 1A                      | Risk Factors                                                                                             |   | 15 |
|                              |                                                                                                     |   |   |
| Item 5                       | Other Information                                                                                   |   | 15 |
|                              |                                                                                                     |   |   |
| Item 6                       | Exhibits                                                                                                 |   | 15 |
|                              |                                                                                                     |   |   |
| Signatures                        |                                                                                                     | 16     |

----

----

|                                                                                                                               |   | April 2,    |    |   | January 1, |   |
|-----------------------------------------------------------------------------------------------------------------------------------------|--------|-------------|---------|--------|------------|--------|
|                                                                                                                               |   | 2011        |    |   | 2011       |   |
|                                                                                                                                    |   | (unaudited) |    |   |       |   |
| ASSETS:                                                                                                                                 |   |        |    |   |       |   |
| Current Assets:                                                                                                                    |   |        |    |   |       |   |
| Cash and cash equivalents                                                                                                          |   | $           | 17,633  |   |       | $      | 15,067 |   |
| Accounts receivable, net                                                                                                           |   |        | 51,514  |   |       |   | 50,457 |   |
| Inventories                                                                                                                        |   |        | 74,992  |   |       |   | 70,373 |   |
| Refundable income taxes                                                                                                            |   |        | 1,681   |   |       |   | 1,911 |   |
| Deferred income taxes                                                                                                              |   |        | 4,970   |   |       |   | 4,597 |   |
| Other current assets                                                                                                               |   |        | 4,280   |   |       |   | 3,281 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| Total current assets                                                                                                               |   |        | 155,070 |   |       |   | 145,686 |   |
| Property and equipment, net                                                                                                        |   |        | 108,416 |   |       |   | 107,879 |   |
| Goodwill                                                                                                                           |   |        | 154,658 |   |       |   | 154,218 |   |
| Intangible assets, net of accumulated amortization                                                                                 |   |        | 39,052  |   |       |   | 39,601 |   |
| Other assets                                                                                                                       |   |        | 3,406   |   |       |   | 2,570 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| Total Assets                                                                                                                       |   | $           | 460,602 |   |       | $      | 449,954 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| LIABILITIES AND SHAREHOLDERS' EQUITY:                                                                                                   |   |        |    |   |       |   |   |   |
| Current Liabilities:                                                                                                               |   |        |    |   |       |   |   |   |
| Accounts payable                                                                                                                   |   | $           | 26,495  |   |       | $      | 23,097 |   |
| Accrued wages and benefits                                                                                                         |   |        | 9,657   |   |       |   | 6,808 |   |
| Other accrued expenses                                                                                                             |   |        | 4,911   |   |       |   | 3,881 |   |
| Accrued income taxes                                                                                                               |   |        | 307     |   |       |   | 233 |   |
| Revolving line of credit                                                                                                           |   |        | 4,646   |   |       |   | 3,692 |   |
| Current portion of capital lease obligations                                                                                       |   |        | 452     |   |       |   | 454 |   |
| Current portion of long-term debt                                                                                                  |   |        | 1,444   |   |       |   | 1,397 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| Total current liabilities                                                                                                          |   |        | 47,912  |   |       |   | 39,562 |   |
| Accrued income taxes                                                                                                               |   |        | 6,588   |   |       |   | 6,564 |   |
| Deferred income taxes                                                                                                              |   |        | 17,463  |   |       |   | 17,692 |   |
| Capital lease obligations, less current portion                                                                                    |   |        | 2,321   |   |       |   | 2,418 |   |
| Long-term debt, less current portion                                                                                               |   |        | 84,000  |   |       |   | 87,349 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| Total Liabilities                                                                                                                  |   |        | 158,284 |   |       |   | 153,585 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| Shareholders' Equity:                                                                                                              |   |        |    |   |       |   |   |   |
| Common Stock, $.0001 par value; 75,000 shares authorized; shares issued April 2, 2011—36,368; January 1, 2011—35,950   |   |        | 4       |   |       |   | 4 |   |
| Additional paid-in capital                                                                                                         |   |        | 281,191 |   |       |   | 279,592 |   |
| Retained earnings                                                                                                                  |   |        | 15,610  |   |       |   | 14,248 |   |
| Accumulated other comprehensive income                                                                                             |   |        | 5,513   |   |       |   | 2,525 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| Total Shareholders' Equity                                                                                                         |   |        | 302,318 |   |       |   | 296,369 |   |
|                                                                                                                               |   |        |    |   |       |   |   |   |
| Total Liabilities and Shareholders' Equity                                                                                         |   | $           | 460,602 |   |       | $      | 449,954 |   |

----

|                                                              |   | Three Months Ended |   |
|-------------------------------------------------------------------|--------|------------------------------|--------|
|                                                              |   | April 2,                |   |   | April 3, |   |
|                                                              |   | 2011                         |   |   | 2010 |   |
|                                                              |   |                         |   |   |   |   |
| Revenue                                                           |   | $                            | 95,778 |   |   | $ | 84,494 |   |
| Cost of revenue                                                   |   |                         | 76,455 |   |   |   | 67,458 |   |
| Gross profit                                                      |   |                         | 19,323 |   |   |   | 17,036 |   |
| Selling, general and administrative expenses                      |   |                         | 15,616 |   |   |   | 12,604 |   |
| Facility closure and severance costs                              |   |                         | 584    |   |   |   | 520 |   |
| Operating Income                                                  |   |                         | 3,123  |   |   |   | 3,912 |   |
|                                                              |   |                         |   |   |   |   |   |   |
| Other (income)/expense:                                           |   |                         |   |   |   |   |   |   |
| Interest expense                                                  |   |                         | 883    |   |   |   | 1,563 |   |
| Derivatives valuation gain                                        |   |                         | -      |   |   |   | (308 | ) |
| Other                                                             |   |                         | 200    |   |   |   | 181 |   |
| Income before income taxes                                        |   |                         | 2,040  |   |   |   | 2,476 |   |
| Income tax expense                                                |   |                         | 678    |   |   |   | 845 |   |
| Net income                                                        |   | $                            | 1,362  |   |   | $ | 1,631 |   |
|                                                              |   |                         |   |   |   |   |   |   |
| Net income per share:                                             |   |                         |   |   |   |   |   |   |
| Basic                                                             |   | $                            | 0.04   |   |   | $ | 0.05 |   |
| Diluted                                                           |   | $                            | 0.04   |   |   | $ | 0.05 |   |
|                                                              |   |                         |   |   |   |   |   |   |
| Weighted average common shares and equivalent shares outstanding: |   |                         |   |   |   |   |   |   |
| Basic                                                             |   |                         | 35,528 |   |   |   | 35,442 |   |
| Diluted                                                           |   |                         | 35,991 |   |   |   | 35,729 |   |

----

|                                                                              |   | Three Months Ended |   |
|-----------------------------------------------------------------------------------|--------|------------------------------|--------|
|                                                                              |   | April 2,                |   |   | April 3, |   |
|                                                                              |   | 2011                         |   |   | 2010 |   |
|                                                                              |   |                         |   |   |   |   |
| Operating activities                                                              |   |                         |   |   |   |   |
| Net income                                                                        |   | $                            | 1,362  |   |   | $ | 1,631 |   |
| Adjustments to reconcile net income to net cash provided by operating activities: |   |                         |   |   |   |   |   |   |
| Depreciation                                                                      |   |                         | 4,583  |   |   |   | 4,453 |   |
| Amortization                                                                      |   |                         | 694    |   |   |   | 733 |   |
| Net (gain) loss on sale of assets                                                 |   |                         | 36     |   |   |   | (42 | ) |
| Deferred income tax provision                                                     |   |                         | (578   | ) |   |   | (265 | ) |
| Stock-based compensation                                                          |   |                         | 1,600  |   |   |   | 299 |   |
| Derivative valuation gain                                                         |   |                         | -      |   |   |   | (308 | ) |
| Foreign currency transaction (gain) loss                                          |   |                         | (508   | ) |   |   | 338 |   |
| Change in operating assets and liabilities:                                       |   |                         |   |   |   |   |   |   |
| Accounts receivable                                                               |   |                         | (454   | ) |   |   | (8,774 | ) |
| Other assets                                                                      |   |                         | (1,794 | ) |   |   | (1,100 | ) |
| Inventories                                                                       |   |                         | (4,117 | ) |   |   | 745 |   |
| Current income taxes                                                              |   |                         | 291    |   |   |   | 541 |   |
| Accounts payable                                                                  |   |                         | 3,035  |   |   |   | 3,993 |   |
| Accrued expenses and other                                                        |   |                         | 4,375  |   |   |   | 434 |   |
|                                                                              |   |                         |   |   |   |   |   |   |
| Net cash provided by operating activities                                         |   |                         | 8,525  |   |   |   | 2,678 |   |
|                                                                              |   |                         |   |   |   |   |   |   |
| Investing activities                                                              |   |                         |   |   |   |   |   |   |
| Purchases of property and equipment                                               |   |                         | (4,021 | ) |   |   | (3,610 | ) |
| Proceeds from the sale of property and equipment                                  |   |                         | 30     |   |   |   | 595 |   |
|                                                                              |   |                         |   |   |   |   |   |   |
| Net cash used in investing activities                                             |   |                         | (3,991 | ) |   |   | (3,015 | ) |
|                                                                              |   |                         |   |   |   |   |   |   |
| Financing activities                                                              |   |                         |   |   |   |   |   |   |
| Proceeds from revolving credit agreement borrowings                               |   |                         | 5,000  |   |   |   | 7,146 |   |
| Payments on revolving credit agreement borrowings                                 |   |                         | (8,000 | ) |   |   | (5,146 | ) |
| Proceeds from (payments on) short term borrowings, net                            |   |                         | 901    |   |   |   | (2,163 | ) |
| Issuance of bank term loan                                                        |   |                         | -      |   |   |   | 2,711 |   |
| Payments on bank term loans and capital lease obligations                         |   |                         | (470   | ) |   |   | (5,240 | ) |
|                                                                              |   |                         |   |   |   |   |   |   |
| Net cash used in financing activities                                             |   |                         | (2,569 | ) |   |   | (2,692 | ) |
| Effect of exchange rate changes on cash                                           |   |                         | 601    |   |   |   | (730 | ) |
|                                                                              |   |                         |   |   |   |   |   |   |
| Net increase (decrease) in cash and cash equivalents                              |   |                         | 2,566  |   |   |   | (3,759 | ) |
| Cash and cash equivalents at beginning of period                                  |   |                         | 15,067 |   |   |   | 14,219 |   |
|                                                                              |   |                         |   |   |   |   |   |   |
| Cash and cash equivalents at end of period                                        |   | $                            | 17,633 |   |   | $ | 10,460 |   |
|                                                                              |   |                         |   |   |   |   |   |   |
| Supplemental disclosures:                                                         |   |                         |   |   |   |   |   |   |
| Cash paid for interest                                                            |   | $                            | 968    |   |   | $ | 1,365 |   |
|                                                                              |   |                         |   |   |   |   |   |   |
| Cash paid for income taxes                                                        |   | $                            | 960    |   |   | $ | 573 |   |

----

|                      |   | April 2, |   |   | January 1, |   |
|---------------------------|--------|---------------|--------|--------|-----------------|--------|
|                      |   | 2011          |   |   | 2011            |   |
|                      |   | (unaudited)   |   |   |            |   |
| Raw material and supplies |   | $             | 15,075 |   |            | $      | 14,407 |   |
| Work-in-process           |   |          | 33,959 |   |            |   | 31,739 |   |
| Finished goods            |   |          | 25,958 |   |            |   | 24,227 |   |
|                      |   |          |   |   |            |   |   |   |
|                      |   | $             | 74,992 |   |            | $      | 70,373 |   |

|                                        |   | April 2, |     |   | January 1, |   |
|---------------------------------------------|--------|---------------|----------|--------|-----------------|--------|
|                                        |   | 2011          |     |   | 2011            |   |
|                                        |   | (unaudited)   |     |   |            |   |
| Land                                        |   | $             | 6,550    |   |            | $      | 6,412 |   |
| Buildings and improvements (20 to 40 years) |   |          | 41,838   |   |            |   | 41,152 |   |
| Machinery and equipment (5 to 15 years)     |   |          | 144,338  |   |            |   | 144,626 |   |
| Office equipment (3 to 5 years)             |   |          | 15,195   |   |            |   | 13,959 |   |
| Construction-in-progress                    |   |          | 8,506    |   |            |   | 7,276 |   |
|                                        |   |          |     |   |            |   |   |   |
|                                        |   |          | 216,427  |   |            |   | 213,425 |   |
| Less accumulated depreciation               |   |          | (108,011 | )      |            |   | (105,546 | ) |
|                                        |   |          |     |   |            |   |   |   |
|                                        |   | $             | 108,416  |   |            | $      | 107,879 |   |

----

|                                                    | Weighted-Average |   | Gross       |   |   |         |   |    | Net         |   |
|---------------------------------------------------------|------------------|--------|-------------|--------|--------|--------------|--------|---------|-------------|--------|
|                                                    | Amortization     |   | Intangible  |   |   | Accumulated  |   |    | Intangible  |   |
|                                                    | Period           |   | Assets      |   |   | Amortization |   |    | Assets      |   |
|                                                    | (unaudited)      |   | (unaudited) |   |   | (unaudited)  |   |    | (unaudited) |   |
| Acquired technology and patents                         |  10 years   |   | $           | 2,338  |   |         | $      | (1,324  | )           |   | $ | 1,014 |   |
| Acquired customers                                      |  18 years   |   |        | 42,584 |   |         |   | (12,323 | )           |   |   | 30,261 |   |
| Non-compete agreements                                  |  5 years    |   |        | 596    |   |         |   | (479    | )           |   |   | 117 |   |
| Intangible assets subject to amortization               |  17 years   |   |        | 45,518 |   |         |   | (14,126 | )           |   |   | 31,392 |   |
|                                                    |             |   |        |   |   |         |   |    |        |   |   |   |   |
| Proprietary processes                                   |  Indefinite |   |        |   |   |         |   |    |        |   |   | 3,570 |   |
| Trademarks                                              |  Indefinite |   |        |   |   |         |   |    |        |   |   | 4,090 |   |
| Indefinite-lived intangible assets, other than goodwill |             |   |        |   |   |         |   |    |        |   |   | 7,660 |   |
|                                                    |             |   |        |   |   |         |   |    |        |   |   |   |   |
| Total                                                   |             |   |        |   |   |         |   |    |        |   | $ | 39,052 |   |

|                                                    | Weighted-Average |   | Gross      |   |   |         |   |    | Net        |   |
|---------------------------------------------------------|------------------|--------|------------|--------|--------|--------------|--------|---------|------------|--------|
|                                                    | Amortization     |   | Intangible |   |   | Accumulated  |   |    | Intangible |   |
|                                                    | Period           |   | Assets     |   |   | Amortization |   |    | Assets     |   |
| Acquired technology and patents          | 10 years    |   | $          | 2,324  |   |         | $      | (1,284  | )          |   | $ | 1,040 |   |
| Acquired customers                                      | 18 years         |   |       | 42,503 |   |         |   | (11,669 | )          |   |   | 30,834 |   |
| Non-compete agreements                                  | 5 years          |   |       | 590    |   |         |   | (442    | )          |   |   | 148 |   |
| Intangible assets subject to amortization               | 17 years         |   |       | 45,417 |   |         |   | (13,395 | )          |   |   | 32,022 |   |
|                                                    |             |   |       |   |   |         |   |    |       |   |   |   |   |
| Proprietary processes                                   | Indefinite       |   |       |   |   |         |   |    |       |   |   | 3,525 |   |
| Trademarks                                              | Indefinite       |   |       |   |   |         |   |    |       |   |   | 4,054 |   |
| Indefinite-lived intangible assets, other than goodwill |             |   |       |   |   |         |   |    |       |   |   | 7,579 |   |
|                                                    |             |   |       |   |   |         |   |    |       |   |   |   |   |
| Total                                                   |             |   |       |   |   |         |   |    |       |   | $ | 39,601 |   |

|                    |   | Three Months Ended |   |
|-------------------------|--------|------------------------------|--------|
|                    |   | April 2,                |   |   | April 3, |   |
|                    |   | 2011                         |   |   | 2010 |   |
|                    |   | (unaudited)                  |   |
| United States           |   | $                            | 70,131 |   |   | $ | 60,710 |   |
| Ireland                 |   |                         | 6,761  |   |   |   | 8,095 |   |
| United Kingdom          |   |                         | 7,767  |   |   |   | 7,179 |   |
| Other foreign countries |   |                         | 11,119 |   |   |   | 8,510 |   |
|                    |   |                         |   |   |   |   |   |   |
| Total net revenues      |   | $                            | 95,778 |   |   | $ | 84,494 |   |

----

|               |   | Three Months Ended |   |
|--------------------|--------|------------------------------|--------|
|               |   | April 2,                |   |   | April 3, |   |
|               |   | 2011                         |   |   | 2010 |   |
|               |   | (unaudited)                  |   |
| Instruments        |   | $                            | 39,204 |   |   | $ | 31,625 |   |
| Implants           |   |                         | 27,227 |   |   |   | 28,212 |   |
| Cases              |   |                         | 23,197 |   |   |   | 18,818 |   |
| Other              |   |                         | 6,150  |   |   |   | 5,839 |   |
|               |   |                         |   |   |   |   |   |   |
| Total net revenues |   | $                            | 95,778 |   |   | $ | 84,494 |   |

|                                                                 |   | Three Months Ended |   |
|----------------------------------------------------------------------|--------|------------------------------|--------|
|                                                                 |   | April 2,                |   |   | April 3, |   |
|                                                                 |   | 2011                         |   |   | 2010 |   |
|                                                                 |   | (unaudited)                  |   |
| Earnings per share - Basic:                                          |   |                         |   |   |   |   |
| Net income                                                           |   | $                            | 1,362  |   |   | $ | 1,631 |   |
| Less:  Undistributed earnings allocated to nonvested stock |   |                         | (11    | ) |   |   | (15 | ) |
| Income available to common shares - Basic                            |   |                         | 1,351  |   |   |   | 1,616 |   |
|                                                                 |   |                         |   |   |   |   |   |   |
| Weighted-average common shares outstanding - Basic                   |   |                         | 35,528 |   |   |   | 35,442 |   |
|                                                                 |   |                         |   |   |   |   |   |   |
| Earnings per share - Basic                                           |   | $                            | 0.04   |   |   | $ | 0.05 |   |
|                                                                 |   |                         |   |   |   |   |   |   |
| Earnings per share - Diluted:                                        |   |                         |   |   |   |   |   |   |
| Net income                                                           |   | $                            | 1,362  |   |   | $ | 1,631 |   |
| Less:  Undistributed earnings allocated to nonvested stock |   |                         | -      |   |   |   | (2 | ) |
| Income available to common shares - Diluted                          |   |                         | 1,362  |   |   |   | 1,629 |   |
|                                                                 |   |                         |   |   |   |   |   |   |
| Weighted-average common shares outstanding - Basic                   |   |                         | 35,528 |   |   |   | 35,442 |   |
| Effect of dilution                                                   |   |                         | 463    |   |   |   | 287 |   |
| Weighted-average common shares outstanding - Diluted                 |   |                         | 35,991 |   |   |   | 35,729 |   |
|                                                                 |   |                         |   |   |   |   |   |   |
| Earnings per share - Diluted                                         |   | $                            | 0.04   |   |   | $ | 0.05 |   |

----

|                                     |   | Three Months Ended |   |
|------------------------------------------|--------|------------------------------|--------|
|                                     |   | April 2,                |   |   | April 3, |   |
|                                     |   | 2011                         |   |   | 2010 |   |
|                                     |   | (unaudited)                  |   |
|                                     |   |                         |   |   |   |   |
| Net Income                               |   | $                            | 1,362  |   |   | $ | 1,631 |   |
| Foreign currency translation adjustments |   |                         | 2,988  |   |   |   | (4,247 | ) |
| Derivative, net of tax benefit (1)       |   |                         | -      |   |   |   | (92 | ) |
|                                     |   |                         |   |   |   |   |   |   |
| Comprehensive income (loss)              |   | $                            | 4,350  |   |   | $ | (2,708 | ) |

----

| Product Category |   | Three Months Ended |   |
|-----------------------|--------|------------------------------|--------|
|                  |   | April 2,                |   |   | April 3, |   |
|                  |   | 2011                         |   |   | 2010 |   |
|                  |   | (unaudited)                  |   |
| Instruments           |   | $                            | 39.2   |   |   | $ | 31.6 |   |
| Implants              |   |                         | 27.2   |   |   |   | 28.2 |   |
| Cases                 |   |                         | 23.2   |   |   |   | 18.8 |   |
| Other                 |   |                         | 6.2    |   |   |   | 5.9 |   |
|                  |   |                         |   |   |   |   |   |   |
| Total                 |   | $                            | 95.8   |   |   | $ | 84.5 |   |

----

----

----

|                           |   | Payments Due By Period |   |
|--------------------------------|--------|---------------------------------------|--------|
|                           |   | Total                                 |   |   | Less than1 year |   |   | 1-3 years |   |   | 4-5 years |   |   | More than5 years |   |
|                           |   | (In Millions)                    |   |
| Long-term debt obligations (1) |   | $                                     | 85.4   |   |   | $ | 1.4 |   |   | $ | - |   |   | $ | 84.0 |   |   | $ | - |   |
| Capital lease obligations      |   |                                  | 4.7    |   |   |   | 0.7 |   |   |   | 2.6 |   |   |   | 1.4 |   |   |   | - |   |
| Operating lease obligations    |   |                                  | 6.1    |   |   |   | 1.7 |   |   |   | 3.3 |   |   |   | 0.7 |   |   |   | 0.4 |   |
| Purchase obligations (2)  |   |                                  | 10.5   |   |   |   | 7.7 |   |   |   | 2.8 |   |   |   | - |   |   |   | - |   |
|                           |   |                                  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Total                          |   | $                                     | 106.7  |   |   | $ | 11.5 |   |   | $ | 8.7 |   |   | $ | 86.1 |   |   | $ | 0.4 |   |

|   | (1) | Represents principal maturities only and, therefore, excludes the effects of interest. There are no scheduled payments for our revolving credit facility prior to maturity. Borrowings under the revolving credit facility bear interest at a variable rate based on the London Interbank Offer Rate (LIBOR) or a base rate determined by the lender’s prime rate plus an applicable margin, as defined in the agreement. The applicable margin for borrowings under the revolving credit agreement ranges from 0.75% to 1.75% for base rate borrowings and 1.75% to 2.75% for LIBOR borrowings, subject to adjustment based on the average availability under the revolving line of credit facility. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | For the purposes of this table, contractual obligations for purchases of goods or services are defined as agreements that are enforceable and legally binding and that specify all significant terms, including: fixed or minimum quantities, fixed, minimum or variable price provisions; and the approximate timing of the transaction. Our purchase orders are normally based on our current manufacturing needs and are fulfilled by our vendors within a short time. We enter into blank orders with vendors that have preferred pricing terms; however, these orders are normally cancelable by us without penalty. Amounts predominantly represent purchase agreements to buy minimum quantities of cobalt chrome and titanium through December 2012. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| 10.60+ |   | Form of Restricted Stock Agreement (Key Employees) issued under Amendment No. 1 to the Amended and Restated Equity Incentive Plan*                                                                            |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                          |
| 31.1   |   | Certification of Chief Executive Officer required by Item 307 of Regulation S-K as promulgated by the Securities and Exchange Commission and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.* |
|   |   |                                                                                                                                                                                                          |
| 31.2   |   | Certification of Chief Financial Officer required by Item 307 of Regulation S-K as promulgated by the Securities and Exchange Commission and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.* |
|   |   |                                                                                                                                                                                                          |
| 32.1   |   | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*                     |

----

|        | SYMMETRY MEDICAL INC. |
|-------------|-----------------------|
|        |                  |   |
|        | By                    | /s/ Thomas J. Sullivan |
|        |                  | Thomas J. Sullivan, |
|        |                  | President and Chief Executive Officer |
|        |                  | (Principal Executive Officer) |
|        |                  |   |
|        | By                    | /s/ Fred L. Hite |
|        |                  | Fred L. Hite, |
|        |                  | Senior Vice President and Chief Financial Officer |
|        |                  | (Principal Financial Officer) |
|        |                  |   |
| May 6, 2011 |                  |   |

----